4. Feld E, Horn L. Emerging role of nivolumab in the management of patients with non -small - cell lung cancer: current data and future perspectives. Onco Ta rgets and Therapy 2017;10:3697 - 708. 5. Brahmer JR. Harnessing the immune system for the treatment of non -small -cell lung cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31:1021 -8. 6. Vansteenkiste J F, Zielinski M, Dahabreh IJ, et al. Association of gene expression signature and clinical efficacy of MAGE -A3 antigen -specific cancer immunotherapeutic as adjuvant therapy in resected stage IB/II non -small cell lung cancer. ASCO Annual Meeting; 2008 May 30-June 3, 2008; Chicago, IL.